These medications work by regulating appetite, boosting feelings of fullness, and improving blood sugar levelsleading to natural, sustainable weight loss
The adverse effect profiles summarized above for liraglutide, semaglutide, and tirzepatide are derived entirely from studies in common obesity and type 2 diabetes
While the first drug in this class, exenatide (Byetta), was approved by the FDA in 2005, more recent drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) outperform the older drugs in the class and other anti-obesity medications
If solid food intake is limited by nausea or early satiety, protein shakes, Greek yogurt, and collagen supplements can help meet minimum requirements without overwhelming a reduced appetite
Abdomen : Often preferred for its ease of access and minimal discomfort